As of November 2026 Verastem Oncology has a market cap of NZ$1.86 Billion. This makes Verastem Oncology the world's 6189th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2026 the market cap of Verastem Oncology was reported to be: